EMvision Medical Devices (ASX:EMV) Long-Term Debt: A$3.23 Mil (As of Dec. 2025)


ASX:EMV EMvision Medical Devices Ltd ASX:EMV
31 GF Score
Price A$1.55
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Long-Term Debt?

EMvision Medical Devices ASX:EMV -0.96% 31 Long-Term Debt is A$3.23 Mil as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

EMvision Medical Devices's Long-Term Debt for the quarter that ended in Dec. 2025 was A$3.23 Mil.

EMvision Medical Devices's quarterly Long-Term Debt increased from Dec. 2024 (A$2.26 Mil) to Jun. 2025 (A$2.65 Mil) and increased from Jun. 2025 (A$2.65 Mil) to Dec. 2025 (A$3.23 Mil).

EMvision Medical Devices's annual Long-Term Debt increased from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$1.77 Mil) and increased from Jun. 2024 (A$1.77 Mil) to Jun. 2025 (A$2.65 Mil).

EMvision Medical Devices  (ASX:EMV) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

EMvision Medical Devices Long-Term Debt Related Terms

EMvision Medical Devices Long-Term Debt Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Long-Term Debt Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 1.77 2.65

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 1.77 2.26 2.65 3.23
ASX:EMV
31GF Score
EMvision Medical Devices Ltd ASX:EMV
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$3.23 Mil mean?
EMvision Medical Devices (ASX:EMV) has a Long-Term Debt of A$3.23 Mil as of Dec. 2025.
Is EMvision Medical Devices' Long-Term Debt too high?
EMvision Medical Devices' current Long-Term Debt is A$3.23 Mil. Overall, EMvision Medical Devices has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' Long-Term Debt compare to ABT and SYK?
EMvision Medical Devices' Long-Term Debt of A$3.23 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. EMvision Medical Devices's current Long-Term Debt is A$3.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current Long-Term Debt of A$3.23 Mil. The current Long-Term Debt is A$3.23 Mil. EMvision Medical Devices' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current Long-Term Debt is A$3.23 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
31GF Score

Get the complete analysis for ASX:EMV

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.55
Price